You are viewing: UK Single-use Bioprocessing Market analysis

The UK Single-use Bioprocessing Market was valued at $1025.3 Million in 2025 and projected to reach to $1850 Million by 2030, representing a compound annual growth rate of 12.5%. The UK single-use bioprocessing market is poised for substantial growth, projected to reach $1,850.0 million by 2030.

UK Single-use Bioprocessing Market Trends and Insights

  • The UK market is driven by increasing adoption of single-use technologies across biopharmaceutical manufacturing, supported by regulatory frameworks and investment in advanced bioprocessing infrastructure.
  • The UK's position as a leading life sciences hub in Europe continues to accelerate demand for flexible, cost-effective manufacturing solutions that single-use systems provide. In the UK, the shift toward single-use bioprocessing reflects broader industry trends toward reducing capital expenditure, minimizing cross-contamination risks, and accelerating time-to-market for biologics.
  • The UK market benefits from strong pharmaceutical and biotechnology sectors, coupled with growing contract manufacturing organization (CMO) activity.
  • Between 2025 and 2030, the UK is expected to see sustained growth as manufacturers scale production capacity and adopt single-use technologies for monoclonal antibodies, cell therapies, and vaccine production..

Key Market Statistics

  • CAGR (2025-2030) 12.5% CAGR
  • Market Size, 2025 ~USD 1025.3 Million
  • Forecast, 2030 ~USD 1850 Million
  • Country UK

UK Single-use Bioprocessing Market Overview

Market Valuation :

The UK single-use bioprocessing market is valued at $1,025.3 million in 2025, with strong growth trajectory driven by biopharmaceutical sector expansion and manufacturing modernization across the country.

Robust Growth Rate :

The UK market is growing at a CAGR of 12.5% from 2025 to 2030, outpacing many European counterparts and reflecting increased investment in advanced bioprocessing technologies and infrastructure.

Regulatory Support :

UK regulatory frameworks and post-Brexit independence have enabled streamlined approval processes for single-use bioprocessing technologies, encouraging adoption among UK-based biopharmaceutical manufacturers.

Infrastructure Investment :

Significant capital investment in UK bioprocessing facilities and manufacturing hubs, particularly in the South East and Greater Manchester, is accelerating the transition to single-use systems.

UK Single-use Bioprocessing Market Dynamics

  • This expansion is underpinned by the UK's position as a leading biopharmaceutical hub, increased adoption of single-use technologies to reduce manufacturing costs and timelines, and growing demand for flexible, scalable production solutions.
  • The market benefits from strong government support for life sciences innovation and strategic investments in manufacturing infrastructure. Key drivers include the rising prevalence of biologics development, increased outsourcing to contract manufacturers, and the shift toward personalized medicine requiring agile production capabilities.
  • UK-based companies are leveraging single-use systems to enhance operational efficiency and reduce contamination risks.
  • Continued regulatory clarity and collaboration between industry and government bodies will further accelerate market penetration across the UK's thriving biopharmaceutical ecosystem..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The UK single-use bioprocessing market will grow from $1,025.3M (2025) to $1,850.0M (2030) at a 12.5% CAGR.
    • The UK's strong life sciences ecosystem and CMO sector are primary drivers of single-use technology adoption.
    • Single-use systems in the UK reduce manufacturing costs and enable faster product launches for biologics.
    • The UK market is supported by regulatory clarity and investment in biopharmaceutical manufacturing capacity.

    Single-use Bioprocessing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONSUMABLES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 13.3% from 2025 to 2030
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 18.03 (2025)
    Revenue Forecast (Billions) ~USD 33.67 (2030)
    Segments Covered Product, Type, Scale Range, Scale

    UK Single-use Bioprocessing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Equipment

    By Type

    • 2D Bags & Containers
    • 3D Bags & Containers
    • Bag Assemblies
    • Bottle Assemblies
    • Filtration Assemblies
    • Mixing System Assemblies
    • Other Assemblies
    • Other Single-Use Consumables
    • Other Single-Use Equipment
    • Single-Use Assemblies
    • Single-Use Bags & Containers
    • Single-Use Bioreactors
    • Single-Use Chromatography Columns
    • Single-Use Chromatography Systems
    • Single-Use Filters
    • Single-Use Filtration Systems
    • Single-Use Mixing Systems
    • Single-Use Sensors

    By Scale Range

    • 101–500 L Bioreactors
    • 11–100 L Bioreactors
    • 501–1,500 L Bioreactors
    • >1,500 L Bioreactors
    • =10 L Bioreactors

    By Scale

    • Manufacturing-Scale Filtration Systems
    • Manufacturing-Scale Mixing Systems
    • Pilot-Scale Filtration Systems
    • Pilot-Scale Mixing Systems
    • R&D-Scale Filtration Systems
    • R&D-Scale Mixing Systems

    Target Audience

    • Biopharmaceutical Manufacturers : UK-based and international pharma companies need market intelligence to optimize manufacturing strategies, evaluate single-use technology investments, and plan capacity expansion in the UK.
    • Contract Manufacturing Organizations : CMOs operating in the UK require detailed market data to benchmark services, identify growth opportunities, and justify investments in single-use bioprocessing infrastructure.
    • Equipment & Technology Suppliers : Bioprocessing equipment manufacturers need UK market insights to develop targeted sales strategies, understand customer requirements, and prioritize product development for the British market.
    • Investment & Private Equity Firms : Investors evaluating UK biotech and pharma opportunities require comprehensive market analysis to assess growth potential, identify acquisition targets, and evaluate portfolio companies.
    • Government & Policy Bodies : UK government agencies and life sciences organizations need market data to inform policy decisions, support industry development initiatives, and track sector performance.

    Key Companies in the UK Single-use Bioprocessing Market

    CompanyHQOwnershipStrongest segments

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise valuation data for the UK market ($1,025.3M in 2025) with detailed forecasts through 2030, enabling accurate budget allocation and investment planning for UK operations.
    • Competitive Landscape Intelligence : Understand UK market dynamics, key players, and competitive positioning specific to the British biopharmaceutical sector to identify partnership and expansion opportunities.
    • Regulatory & Policy Insights : Access analysis of UK-specific regulatory frameworks, post-Brexit implications, and government support initiatives driving single-use technology adoption in the country.
    • Growth Driver Analysis : Identify UK-specific factors fueling 12.5% CAGR growth, including manufacturing hub development, contract manufacturer expansion, and biologics pipeline acceleration.
    • Strategic Decision Support : Make informed decisions on market entry, facility location, technology investment, and partnership strategies tailored to UK market conditions and growth trajectories.

    Frequently asked questions

    What is the current size of the UK single-use bioprocessing market?

    The UK single-use bioprocessing market is estimated at $1,025.3 million in 2025.

    What is the projected size of the UK market by 2030?

    The UK single-use bioprocessing market is forecast to reach $1,850.0 million by 2030.

    What is the growth rate of the UK single-use bioprocessing market?

    The UK market is expected to grow at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2030.

    Why is the UK adopting single-use bioprocessing technologies?

    The UK is adopting single-use technologies to reduce capital costs, minimize contamination risks, accelerate time-to-market, and support flexible manufacturing for biologics and cell therapies.

    Which sectors in the UK are driving single-use bioprocessing demand?

    The UK's biopharmaceutical manufacturing, contract manufacturing organizations (CMOs), monoclonal antibody production, cell therapy, and vaccine manufacturing sectors are primary drivers of demand.

    RESEARCH METHODOLOGY

    This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioprocessing market. The secondary sources used for this study include the World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), the National Institute for Bioprocessing Research and Training (NIBRT), the Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), the European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), the National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioprocessing and Biotechni ques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After acquiring foundational knowledge about the global single-use bioprocessing market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

    These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

    The following is a breakdown of the primary respondents:

    Single-use Bioprocessing Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    After arriving at the overall market size from the estimation process, the total market was split into several segments and subsegments.

    Single-use Bioprocessing Market

    Data Triangulation

    After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Single-use bioprocessing refers to the use of disposable, pre-sterilized equipment and consumables in the production of biopharmaceutical products. Single-use technologies (SUTs) include a range of products, such as bioreactors, mixers, filters, tubing, connectors, and storage bags, all designed for one-time use. Key benefits of single-use bioprocessing include reduced risk of cross-contamination, low capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive to produce biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

    Stakeholders

    • Single-use bioprocessing equipment and consumables manufacturing companies
    • Single-use bioprocessing equipment and consumables distributors
    • Pharmaceutical and biotechnology companies
    • Contract manufacturing companies (CMOs)
    • Contract research organizations (CROs)
    • Academic and research institutes
    • Life science companies
    • Market research and consulting firms
    • Venture capitalists and investors
    • Government organizations
    • Private research firms

    Report Objectives

    • To define, describe, and forecast the single-use bioprocessing market, by product, application, workflow, molecule type, and end user, in terms of value
    • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
    • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile key players in the single-use bioprocessing market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments in the single-use bioprocessing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
    • To benchmark players within the single-use bioprocessing market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

     

    Get the Full Single-use Bioprocessing Market Report

    Full forecast, segment splits, and company analysis for all Single-use Bioprocessing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status